CM

Casey Cameron McComas

Pfizer: 16 patents #226 of 5,153Top 5%
Merck: 13 patents #850 of 9,382Top 10%
CT Cyteir Therapeutics: 8 patents #1 of 7Top 15%
AP Acurx Pharmaceuticals: 3 patents #8 of 22Top 40%
MS Msd Italia S.R.L.: 2 patents #2 of 58Top 4%
Overall (All Time): #72,649 of 4,157,543Top 2%
42
Patents All Time

Issued Patents All Time

Showing 25 most recent of 42 patents

Patent #TitleCo-InventorsDate
12064419 Methods of using RAD51 inhibitors for treatment of pancreatic cancer Alfredo C. Castro, Melinda DAY, Tyler MACLAY, Kevin MILLS, Joseph P. Vacca 2024-08-20
11932636 RAD51 inhibitors Jean-Marc Lapierre, Joseph P. Vacca 2024-03-19
11607404 Combinations of RAD51 and PARP inhibitors Alfredo C. Castro, Melinda DAY, Tyler MACLAY, Kevin MILLS, Joseph P. Vacca 2023-03-21
11291655 RAD51 inhibitors Alfredo C. Castro, Joseph P. Vacca 2022-04-05
11247988 RAD51 inhibitors Jean-Marc Lapierre, Joseph P. Vacca 2022-02-15
11084812 RAD51 inhibitors Alfredo C. Castro, Joseph P. Vacca, Tyler MACLAY 2021-08-10
11001592 DNA polymerase IIIC inhibitors and use thereof Xiang Yu, Li Xing, Minghua Wang, Michael SILVERMAN, Richard Soll 2021-05-11
10836772 DNA polymerase IIIC inhibitors and use thereof Xiang Yu, Li Xing, Minghua Wang, Michael SILVERMAN, Richard Soll 2020-11-17
10723741 DNA polymerase IIIC inhibitors and use thereof Xiang Yu, Li Xing, Minghua Wang, Michael SILVERMAN, Richard Soll 2020-07-28
10590122 RAD51 inhibitors Alfredo C. Castro, Joseph P. Vacca, Tyler MACLAY 2020-03-17
10562909 Fused quadracyclic compounds, compositions and uses thereof Michael H. Serrano-Wu, Joseph P. Vacca 2020-02-18
10336746 RAD51 inhibitors Alfredo C. Castro, Joseph P. Vacca, Tyler MACLAY 2019-07-02
10059718 Fused quadracyclic compounds, compositions and uses thereof Michael H. Serrano-Wu, Joseph P. Vacca 2018-08-28
9914736 TrKA kinase inhibitors, compositions and methods thereof Helen J. Mitchell, Mark E. Fraley, Andrew Cooke, Craig A. Stump, Xu-Fang Zhang +6 more 2018-03-13
9862716 TRKA kinase inhibitors, compositions and methods thereof Helen J. Mitchell, Mark E. Fraley, Andrew Cooke, Craig A. Stump, Yi-Heng Chen +10 more 2018-01-09
9815846 TrkA kinase inhibitors, compositions and methods thereof Helen J. Mitchell, Mark E. Fraley, Andrew Cooke, Craig A. Stump, Yi-Heng Chen +13 more 2017-11-14
9663513 Pyrimidine PDE10 inhibitors Scott D. Kuduk, Thomas S. Reger 2017-05-30
9573939 Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases Nigel J. Liverton, Joerg Habermann, Uwe Koch, Frank Narjes, Peng Li +8 more 2017-02-21
9549921 Heterocyclic compounds and methods of use thereof for the treatment of hepatitis C Shuwen He, Zhong Lai, Xing Dai, Dong Xiao, Clare London +6 more 2017-01-24
9549917 Heterocyclic-substituted benzofuran derivatives and methods of use thereof for the treatment of viral diseases Nigel J. Liverton, Joerg Habermann, Uwe Koch, Frank Narjes, Peng Li +10 more 2017-01-24
9364482 Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases Xing Dai, Hong Liu, Anandan Palani, Shuwen He, Ravi Nargund +6 more 2016-06-14
9353104 Substituted pyridizinone derivatives as PDE10 inhibitors Scott D. Kuduk, Thomas S. Reger, Changhe Qi 2016-05-31
9284302 Cyclobutyl benzimidazoles as PDE 10 inhibitors Scott D. Kuduk, Thomas S. Reger 2016-03-15
9273033 Substituted pyridone derivatives as PDE10 inhibitors Scott D. Kuduk, Thomas S. Reger 2016-03-01
9265773 Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases Nigel J. Liverton, Joerg Habermann, Uwe Koch, Frank Narjes, Peng Li +12 more 2016-02-23